Skip to content

Ambenonium

Cholinesterase Inhibitor — NERVOUS SYSTEM

Also known as: ambenonium chloride, ambestigmin chloride, mytelase, mytelase chloride

OfmFDA approvedATC N07AA30

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Ambenonium is an ofm drug in the Cholinesterase Inhibitor class catalogued in DrugCentral. It was first approved by the FDA in 1956. Its mechanism of action is classified as Cholinesterase Inhibitors. DrugCentral lists 3 molecular targets, including ACHE, Ache and ACHE. Recorded indications include Myasthenia gravis.

  • Approval status: ofm (first approved 1956 by the FDA).
  • Drug class: Cholinesterase Inhibitor.
  • Mechanism of action: Cholinesterase Inhibitors.
  • Molecular targets: ACHE, Ache and ACHE (3 listed in DrugCentral).
  • Indications: Myasthenia gravis.
  • ATC code: N07AA30 (Anticholinesterases).
  • Molecular formula: C28H42Cl2N4O2; molecular weight 537.57 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Myasthenia gravis

Contraindications (4)

  • Asthma
  • Gastrointestinal obstruction
  • Parkinsonism
  • Urinary tract obstruction

Mechanism & targets

Mechanism of action (MoA)Cholinesterase Inhibitors
Established pharmacologic classCholinesterase Inhibitor

Molecular targets (3)

TargetGeneActionActivity
AcetylcholinesteraseACHEunknownIC50 9.92
AcetylcholinesteraseAcheunknownKd 4.34
AcetylcholinesteraseACHEinhibitor—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1956-05-01FDA—SANOFI AVENTIS US

ATC classification

ATC codeTherapeutic hierarchy
N07AA30NERVOUS SYSTEM › OTHER NERVOUS SYSTEM DRUGS › PARASYMPATHOMIMETICS › Anticholinesterases

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Ambenonium is on its molecule page.

Molecular formulaC28H42Cl2N4O2
Molecular weight537.57 g/mol
CAS number7648-98-8
InChIKeyOMHBPUNFVFNHJK-UHFFFAOYSA-P
PubChem CID2131
CC[N+](CC)(CCNC(=O)C(=O)NCC[N+](CC)(CC)CC1=C(Cl)C=CC=C1)CC1=C(Cl)C=CC=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Ambenonium used for?

DrugCentral lists the following indications for Ambenonium: Myasthenia gravis.

How does Ambenonium work?

Ambenonium is classified as Cholinesterase Inhibitors; its molecular targets in DrugCentral include ACHE, Ache and ACHE (inhibitor).

When was Ambenonium first approved?

Ambenonium was first approved by the FDA in 1956.

What drug class does Ambenonium belong to?

Ambenonium is in the Cholinesterase Inhibitor class.

What is the chemical formula of Ambenonium?

Ambenonium has the molecular formula C28H42Cl2N4O2 and a molecular weight of 537.57 g/mol.

Browse: all drugs starting with A · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFM
First approval1956-05-01
AgencyFDA
Targets3
Indications1
FormulaC28H42Cl2N4O2
DrugCentral ID146
Interactive profile